Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management : A Scientific Statement From the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases
The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infections have occurred since then, necessitating a scientific statement update. An 11-member writing group was identified and included recognized experts in cardiology and infectious diseases, with a career focus on cardiovascular infections. The group initially met in October 2022 to develop a scientific statement that was drafted with front-line clinicians in mind and focused on providing updated clinical information to enhance outcomes of patients with cardiovascular implantable electronic device infection. The current scientific statement highlights recent advances in prevention, diagnosis, and management, and how they may be incorporated in the complex care of patients with cardiovascular implantable electronic device infection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:149 |
|---|---|
| Enthalten in: |
Circulation - 149(2024), 2 vom: 09. Jan., Seite e201-e216 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Baddour, Larry M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AHA Scientific Statements |
|---|
| Anmerkungen: |
Date Completed 10.01.2024 Date Revised 03.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1161/CIR.0000000000001187 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365383155 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365383155 | ||
| 003 | DE-627 | ||
| 005 | 20240404234439.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIR.0000000000001187 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM365383155 | ||
| 035 | |a (NLM)38047353 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Baddour, Larry M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management |b A Scientific Statement From the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.01.2024 | ||
| 500 | |a Date Revised 03.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infections have occurred since then, necessitating a scientific statement update. An 11-member writing group was identified and included recognized experts in cardiology and infectious diseases, with a career focus on cardiovascular infections. The group initially met in October 2022 to develop a scientific statement that was drafted with front-line clinicians in mind and focused on providing updated clinical information to enhance outcomes of patients with cardiovascular implantable electronic device infection. The current scientific statement highlights recent advances in prevention, diagnosis, and management, and how they may be incorporated in the complex care of patients with cardiovascular implantable electronic device infection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a AHA Scientific Statements | |
| 650 | 4 | |a defibrillators, implantable | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a echocardiography, transesophageal | |
| 650 | 4 | |a endocarditis | |
| 650 | 4 | |a infection | |
| 700 | 1 | |a Esquer Garrigos, Zerelda |e verfasserin |4 aut | |
| 700 | 1 | |a Rizwan Sohail, M |e verfasserin |4 aut | |
| 700 | 1 | |a Havers-Borgersen, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Krahn, Andrew D |e verfasserin |4 aut | |
| 700 | 1 | |a Chu, Vivian H |e verfasserin |4 aut | |
| 700 | 1 | |a Radke, Connie S |e verfasserin |4 aut | |
| 700 | 1 | |a Avari-Silva, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a El-Chami, Mikhael F |e verfasserin |4 aut | |
| 700 | 1 | |a Miro, Jose M |e verfasserin |4 aut | |
| 700 | 1 | |a DeSimone, Daniel C |e verfasserin |4 aut | |
| 700 | 0 | |a American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young (Young Hearts); and Council on Clinical Cardiology |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation |d 1950 |g 149(2024), 2 vom: 09. Jan., Seite e201-e216 |w (DE-627)NLM000039020 |x 1524-4539 |7 nnns |
| 773 | 1 | 8 | |g volume:149 |g year:2024 |g number:2 |g day:09 |g month:01 |g pages:e201-e216 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIR.0000000000001187 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 149 |j 2024 |e 2 |b 09 |c 01 |h e201-e216 | ||